In 5 days, it will be too late to enjoy the Early Bird offer!
If you are interested in attending BioFIT on 4th and 5th December 2018 in Lille, France, enjoy the Early Bird offer before it ends, after this Saturday it will be too late!
|
5 days left to save money! Read More »
Book your booth now!
As an Exhibitor, you will gain high visibility among top leaders in the Life Sciences sector.
Ideally located at the focal point of the event, the Exhibition area enables participants to access key information, expand their network, highlight their skills, services and innovations and enhance their visibility.
6m² fitted booth – € 2,200
(1 partnering pass included)
9m² fitted booth – € 3,300
(1 partnering pass included)
12m² fitted booth – €4,400
(1 partnering pass included)
18m² fitted booth – €6,600
(2 partnering passes included)
|
First come, first served: Boost your presence at BioFIT 2018! Read More »
BioFIT 2018 will host the 4th edition of the “R&D dating for Animal Health and Innovation” business convention, at the French association for the animal healthcare industry (SIMV)’s initiative, on the 4th and 5th of December 2018, in Lille.
Today, public-private and private-private partnerships are thought to be the leverage that is needed for innovation. That is why the SIMV launched the “R&D dating for Animal Health and Innovation”, which strives to initiate high-level exchanges between research departments of the veterinary medicine and diagnostics industry and public research, as well as with biotechnology companies (start-ups).
By enabling face-to-face encounters, the event will enhance the visibility of cutting-edge research in France and in Europe, encourage investments and lead to therapeutic innovation.
About SIMV
While being the organiser of this meeting, the SIMV intends to federate research actors by actively contributing to meet the needs in animal health innovation. In particular, enhanced research is needed to supplement and renew the therapeutic arsenal for the treatment of infectious diseases and therefore research and innovation on this topic should be promoted.
[Hosted events] R&D dating for animal health and innovation Read More »
Many thanks to LFB for joining BioFIT 2018 as a Contributing Sponsor!
Since it was formed in 1994, the LFB Group has been developing, manufacturing and marketing biological medicinal products, for diseases that are always serious and often rare. The LFB Group is now one of the leading European players in biopharmaceutical, its products are aimed at health professionals, mainly hospital-based, these are medicinal products derived from living organisms in three major fields of therapy: immunology, haemostasis and intensive care.
The LFB group is a biopharmaceutical company, one of the rare manufacturers in the world with expertise in different bioproduction techniques, offering plasma-derived medicinal products, recombinant medicinal products and advanced therapy treatments such as cell therapies. The LFB Group’s strategy is focused on international growth and an active research and development policy in its fields of therapeutic excellence.
LFB is a public company and the Group is growing in a competitive sector, with medicinal products sold in nearly 60 countries. Over 2000 employees of the LFB Group, both in France and worldwide, are totally committed to meeting the needs of hundreds of thousands of patients. Every year, LFB’s 23 biopharmaceuticals are used to treat hundreds of thousands of patients with serious and often rare diseases.
Join key BioFIT 2018 sponsors such as Bayer, Roche, MSD, Boehringer Ingelheim, Pfizer and VIB, to have the opportunity to:
They were the BioFIT 2017 sponsors: Sanofi, Pfizer, Bayer, Genfit, Lilly, MSD, Merck, Boehringer Ingelheim, Johnson & Johnson Innovation, Novo Nordisk, LFB, PPRS and Trianni.
For more information about the sponsorship opportunities, visit the dedicated site page.
We are very honoured to count LFB among the Sponsors of BioFIT 2018 Read More »
#BioFIT2018 preliminary programme is now available
In this brochure, you will find all the information you need about the 7th edition of the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation in the field of Life Sciences.
|
#BioFIT 2018 preliminary programme is available! Read More »
Many thanks to Pfizer for joining BioFIT 2018 as a Bronze Sponsor!
Pfizer is a leading research-based biopharmaceutical company. They apply science and their global resources to deliver innovative therapies that extend and significantly improve lives. They make medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place, as well as some of the world’s best-known consumer healthcare brands.
Pfizer teams work in developed and emerging markets to treat, cure and eradicate life-threatening conditions and challenge some of the most feared diseases of our time. Pfizer also collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.
Join key BioFIT 2018 sponsors such as Bayer, Roche, MSD, Boehringer Ingelheim and LFB, to have the opportunity to:
They were the BioFIT 2017 sponsors: Sanofi, Pfizer, Bayer, Genfit, Lilly, MSD, Merck, Boehringer Ingelheim, Johnson & Johnson Innovation, Novo Nordisk, LFB, PPRS and Trianni.
For more information about the sponsorship opportunities, visit the dedicated site page.
We are very honoured to count Pfizer among the Sponsors of BioFIT 2018 Read More »
Are you a tech transfer with a ready-to-be-licensed technology?
Apply to the presentation sessions to:
1. Apply
Dedicated to TTO, universities or related structures that have ready-to-be-licensed technologies
2. Be selected
A jury of experts will select the most innovative projects
3. Exhibit
The selected candidates will benefit from a poster’s exhibition at bioFIT describing their out-licensing opportunities
4. Pitch
Presentations of the selected projects to potential industrial partners during BioFIT
5. Find partners
The presenters can easily find industrial partners who could in-license their assets
|
Apply to the Licensing Opportunity Presentations Read More »
Conference Insight – Agnostic or pure players in the biotech sector: Who is getting prominent in the early-stage financing rounds?
4 Dec 2018 9:30 – 11:00 am
The seed investment market is composed of actors with really diverse degree of specialisation (from totally agnostic and multi-sectorial to pure players in specific therapeutic indications). Do the most specialised funds attract more generalist ones in the financing rounds? What is the respective importance today in the amount of seed investment of the multi-sectorial funds, the 100% healthcare orientated funds and the pure players in the biotech sector.[/vc_column_text][vc_column_text]They will share their experience:
|
Conference Insight Read More »
Discover the new speakers that will share their vision at BioFIT 2018:
Over 70 international experts from academia, industry and biotech will address issues to learn about the latest trends and explore hands-on approaches to tech transfer and open innovation in the field of Life Sciences, by sharing their experience and knowledge.
Alain Chevallier
Life Sciences Partner
Truffle Capital
Marco A. Chacon
Assistant Vice President of Industry Alliances
University of Maryland Baltimore
Rodolphe Besserve
Head SuFT Advisory, Start-up & French Techs
Société Générale Corporate Investments and Banking
Zishan Haroon
Chairman and General Partner
JulzCo
|
|
They will speak at BioFIT 2018! Read More »
Are you an entrepreneur who has created an innovative company (less than 5 years old or to be created)?
Apply to the presentation sessions to:
1. Apply before 30th June
Dedicated to entrepreneurs who have created an innovative company (less than 5 years old or to be created)
2. Be selected
A jury of experts will select the most innovative projects
3. Exhibit
The selected candidates will benefit from a space at BioFIT to hold their one-to-one meetings
4. Pitch
A 6-7 minute presentation of each selected project to potential partners and investors during BioFIT
5. Receive a speed-mentoring
A jury composed of pharma and investors will give feedback and advice to the presenters
6. Be awarded
The most innovative start-up will be awarded by the jury of experts of BioFIT
|
Apply to the Start-up Slams Read More »
With more than 1,000 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences.
Learn more
Organised by:
WITH THE SUPPORT OF:
INSTITUTIONAL PARTNERS:
"*" indicates required fields
Palais de la Musique et des Congrès
Place de Bordeaux
67000, Strasbourg, FRANCE
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of BioFIT. And some are passing themselves off as being BioFIT organisation members and asking you to pay. Please note that the BioFIT team will never sell you the BioFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.
